Added to YB: 2017-11-22
Pitch date: 2017-11-22
RIGL:US [bullish]
Rigel Pharmaceuticals, Inc.
+5.1%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.
Market Cap
$761.3M
Pitch Price
$38.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
5.61
P/E
6.77
EV/Sales
2.43
Sector
Biotechnology
Category
N/A
Show full summary:
Rigel Pharmaceuticals Inc RIGL:US
A summary for this pitch has not been created yet.
Read full article (0 min)